ABCA1 and coronary artery disorder: In addition, ABCA1 mRNA levels in EAT were reduced in the subgroup of patients with CAD and concomitant carotid artery disease or peripheral artery disease (i.e. proven multifocal atherosclerosis) compared with the NCAD group (Fig. 1C).